XML 45 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT INFORMATION (Tables)
 9 Months Ended
Jul. 31, 2017
Segment Reporting [Abstract]  
Segment Profitability and Segment Assets
The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below:
 
Three Months Ended
 
Nine Months Ended
 
July 31,
 
July 31,
 
2017
 
2016
 
2017
 
2016
 
(in millions)
Net Revenue:
 
 
 
 
 
 
 
Life Sciences and Applied Markets
$
531

 
$
504

 
$
1,594

 
$
1,525

Diagnostics and Genomics
197

 
180

 
562

 
516

Agilent CrossLab
386

 
360

 
1,127

 
1,050

Total net revenue
$
1,114

 
$
1,044

 
$
3,283

 
$
3,091

 
 
 
 
 
 
 
 
Segment Income From Operations:


 


 
 
 
 
Life Sciences and Applied Markets
$
113

 
$
96

 
$
349

 
$
304

Diagnostics and Genomics
33

 
34

 
105

 
76

Agilent CrossLab
90

 
82

 
246

 
232

Total segment income from operations
$
236

 
$
212

 
$
700

 
$
612

The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.  
 
July 31,
2017
 
October 31,
2016
 
(in millions)
Segment Assets:
 
 
 
Life Sciences and Applied Markets
$
1,735

 
$
1,687

Diagnostics and Genomics
2,095

 
1,960

Agilent CrossLab
1,117

 
1,082

Total segment assets
$
4,947

 
$
4,729
Reconciliation of segment results to total enterprise results
The following table reconciles reportable segments’ income from operations to Agilent’s total enterprise income before taxes: 
 
Three Months Ended
 
Nine Months Ended
 
July 31,
 
July 31,
 
2017
 
2016
 
2017
 
2016
 
(in millions)
Total reportable segments’ income from operations
$
236

 
$
212

 
$
700

 
$
612

Asset impairments
—

 
(4
)
 
—

 
(4
)
Transformational initiatives
(3
)
 
(11
)
 
(5
)
 
(32
)
Amortization of intangibles
(27
)
 
(37
)
 
(89
)
 
(120
)
Acquisition and integration costs
(4
)
 
(11
)
 
(25
)
 
(28
)
Business exit and divestiture costs (primarily our NMR business)
—

 
(1
)
 
—

 
(7
)
Pension settlement gain
—

 
—

 
32

 
1

Pension curtailment gain
—

 
—

 
—

 
15

Other
(1
)
 
(2
)
 
(5
)
 
(5
)
Interest income
6

 
3

 
15

 
8

Interest expense
(19
)
 
(17
)
 
(59
)
 
(53
)
Other income (expense), net
5

 
2

 
13

 
6

Income before taxes, as reported
$
193

 
$
134

 
$
577

 
$
393